Skip to content

Establishment Labs ESTA Cumulative Cost Basis

Cumulative Cost Basis at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
AbbVie logo
AbbVieABBV
Globus Medical logo
Globus MedicalGMED
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
Stryker logo
StrykerSYK

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentGross.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's cumulative cost basis?
Establishment Labs (ESTA) reported cumulative cost basis of $101.08M in Q1 2026.
How has Establishment Labs's cumulative cost basis changed year-over-year?
Establishment Labs's cumulative cost basis increased by 3.0% year-over-year, from $98.18M to $101.08M.
What is the long-term trend for Establishment Labs's cumulative cost basis?
Over 5 years (2020 to 2025), Establishment Labs's cumulative cost basis has grown at a 31.6% compound annual growth rate (CAGR), from $25.84M to $101.83M.